FDA grants fast-track status to SolasCure’s gel for calciphylaxis ulcers

The fast track status signifies the potential of the gel to broaden its therapeutic applications in chronic wound healing, accelerating its availability to patients. Credit: Diana Polekhina on Unsplash.